Catheter-related clotting not reduced by dalteparin.
Adrian
A
Burton
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D002408:Catheters, Indwelling / Q000009:adverse effects*; D017326:Clinical Trials, Phase III as Topic; D017985:Dalteparin / Q000494:pharmacology* / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D017985:Dalteparin